NEW YORK (TheStreet) -- Today we crunch the numbers on 11 companies that report quarterly earnings before the opening bell Thursday.
Rather than profile each stock individually, I will crunch the numbers in the tables below for you. (See pages 2 and 3 for the tables.)
The biggest year-to-date gainer is Royal Gold (RGLD - Get Report) ($66.69), up 45%. Analysts expect the company to report earnings per share of 23 cents before the opening bell on Thursday. The acquisition and manager of precious metals royalties traded to its 2014 high at $72.90 on March 14, three days before the 2014 high for Comex gold, then the stock traded as low as $62.02 on March 27. The high for gold was $1392.6 an ounce.
The weekly chart for Royal Gold is neutral with the five-week modified moving average at $65.38 and the 200-week simple moving average at $62.76. The 12x3x3 weekly slow stochastic is declining, so a close this week below $65.38 would shift the weekly chart to negative. Weekly and monthly value levels are $64.44 and $58.48, respectively, with a quarterly pivot at $66.48 and annual and semiannual risky levels at $67.13 and $69.05, respectively.The second best year-to-date gainer is Mylan (MYL) ($50.88), up 17%. Analysts expect the maker of generic drugs to report EPS of 63 cents before the opening bell on Thursday. Mylan traded to an all-time intraday high at $57.52 on March 4, but its parabolic bubble then popped with a trade as low as $44.74 on April 15. The weekly chart shifts to negative given a close this week below its five-week MMA at $49.77. Quarterly and weekly value levels are $45.97 and $45.75, respectively, with a monthly risky level at $54.78. In third place to the upside year-to-date is Goldcorp (GG)($24.85), up 15%. Analysts expect the gold miner to report EPS of 14 cents before the opening bell on Thursday. Like Royal Gold, Goldcorp traded to its 2014 high on March 14. Goldcorp's high was $29.27. Then the stock slumped as low as $23.14 on April 21. The weekly chart stays negative given a close this week below its five-week MMA at $25.05. Monthly and quarterly value levels are $21.96 and $16.08, respectively, with a weekly pivot at $24.14 and semiannual risky levels at $32.82 and $41.33. The biggest year-to-date loser is Blue Nile (NILE) ($34.74), down 26%. Analysts expect the online retailer of diamonds and fine jewelry to report EPS of 7 cents before the opening bell on Thursday. The stock set a 52-week intraday high at $49.13 on Dec. 30 then traded as low as $32.60 on Feb. 14. The weekly chart stays negative but oversold given a close this week below its five-week MMA at $35.16. A semiannual value level is $23.15 with a weekly pivot at $34.48 and monthly and quarterly risky levels at $40.97 and $41.48, respectively. Another double-digit year-to-date loser is MasterCard (MA) ($72.03), down 14%. Analysts' expect the credit card company to report EPS of 72 cents before the opening bell on Thursday. The stock set an all-time intraday high at $84.74 on Jan. 10 then traded as low as $68.68 as the market bubble popped. The stock is on the cusp of its 200-day SMA at $72.28. The weekly chart is neutral with its five-week MMA at $73.17 with rising stochastics. Weekly and semiannual value levels are $68.12 and $64.93, respectively, with a semiannual pivot at $69.06 and quarterly and monthly risky levels at $86.90 and $90.52, respectively. One more double-digit year-to-date loser is Cigna Corp (CI) ($77.85), down 11%. Analysts expect the provider of health care benefits products and services to report EPS of $1.53 before the opening bell on Thursday. The stock set an all-time intraday high at $90.63 on Jan. 10 then traded as low as $73.47 as the bubble popped. The stock is below its 200-day SMA at $80.86. The weekly chart is negative with its five-week MMA at $78.79. Semiannual value levels are $77.19 and $76.77 with a weekly pivot at $78.08 and quarterly and monthly risky levels at $86.59 and $86.80, respectively. Your investment policy among these stocks depends on whether or not you are a buyer on weakness or a seller of strength. We advocate using a good 'til canceled limit order to buy weakness to a value level or to sell strength to a risky level.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts